EGFRdelEx19 and KRAS Exon 2 Mutation Detection in EBUS-TBNA
NCT02975752
·
clinicaltrials.gov ↗
COMPLETED
Status
48
Enrollment
OTHER
Sponsor class
Conditions
Lung Adenocarcinoma Metastatic
Interventions
GENETIC:
LC-RT-PCR and NGS
Sponsor
University Hospital, Essen